Urotronic today announced that it received FDA approval for its Optilume urethral drug-coated balloon for male urethral strictures.
Plymouth, Minnesota–based Urotronic designed the paclitaxel-coated balloon to inhibit new scar tissue growth that can occur after endoscopic dilations. Urethral strictures are scars in or around the urethra that can restrict urine flow from the bladder.
Get the full story on our sister site, Medical Tubing + Extrusion.